Additionally, in a mouse model, genetic inactivation of ACAT1/SOAT1 was recently shown to benefit a rare pediatric neurodegenerative disease, Niemann-Pick type C1 (NPC1) [87]. The gene discussed is NPC1; the disease is neurodegenerative disease.